Form D · Hedge Fund
Alger Life Sciences Innovation Fund LP
New York, NY · CIK 0001923614
Offering snapshot reported Apr 10, 2026 · SEC filing
- Reported sold
- $30.3M Indefinite offering
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- May 20, 2022 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$17,311,618 → $30,286,264
- Reported investors19 → 13
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2026 | Amendment | $30,286,264 | $12,974,646vs Apr 11, 2025 | 13 | SEC filing |
| Apr 11, 2025 | Amendment | $17,311,618 | -$6,406,642vs Apr 12, 2024 | 19 | SEC filing |
| Apr 12, 2024 | Amendment | $23,718,260 | $11,500,313vs Apr 12, 2023 | 19 | SEC filing |
| Apr 12, 2023 | Amendment | $12,217,947 | No comparison | 13 | SEC filing |
| Apr 18, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-442344
Clarification of Item 11: The minimum initial investment amount is $500,000, and the minimum additional investment amount is $250,000, which may be reduced or waived by the General Partner in its sole discretion.
Source: Form D, filed Apr 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ALGER LIFE SCIENCES INNOVATION FUND LP
Investment adviser: FRED ALGER MANAGEMENT, LLC
- Gross asset value
- $30.4M
- Beneficial owners
- 22
- ADV minimum commitment
- $500K
Reported in Form ADV on Sep 17, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
DELOITTE & TOUCHE LLP
PCAOB 34
BNP PARIBAS SECURITIES CORP.
SEC 8-32682
GOLDMAN SACHS & CO. LLC
SEC 8-129
BNP PARIBAS SECURITIES CORP.
CRD 15794 · SEC 8-32682
GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129
Filing source
Form ADV 2133379 · Sep 17, 2026 · Schedule D 7.B.(1), fund 805-6709220239
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Alger Alternative Holdings Ii, Llc | Promoter |
| Daniel Cayley Chung | Director, Executive |
| N/A Fred Alger Management, Llc | Promoter |
| Robert Louis Kincel | Director, Executive |
| Hal Liebes | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10004